A Controlled Trial of Naltrexone Augmentation of Nicotine Replacement Therapy for Smoking Cessation
Author(s) -
Stephanie S. O’Malley,
Judith L. Cooney,
Suchitra KrishnanSarin,
Joel A. Dubin,
Sherry A. McKee,
Ned L. Cooney,
Amy Blakeslee,
Boris Meandzija,
Denise Romano-Dahlgard,
Ran Wu,
Robert Makuch,
Peter Jatlow
Publication year - 2006
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.166.6.667
Subject(s) - abstinence , medicine , naltrexone , placebo , nicotine patch , nicotine replacement therapy , smoking cessation , weight gain , randomization , anesthesia , confidence interval , nicotine , odds ratio , randomized controlled trial , psychiatry , body weight , antagonist , receptor , alternative medicine , pathology
Many smokers remain refractory to current therapies, which only partially address weight gain after smoking cessation. Thus, this study evaluated whether naltrexone hydrochloride augmentation of nicotine patch therapy improves smoking abstinence and reduces postcessation weight gain more than nicotine patch therapy alone and at what dose.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom